(Q40408075)

English

Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells

scientific article published on August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells (English)

1 reference

Europe PubMed Central

20 September 2017

object named as

Graham P Cook

2

0 references

object named as

Rob C Hoeben

5

0 references

author name string

Graham Bottley

1

1 reference

Europe PubMed Central

20 September 2017

Josephine L Meade

3

1 reference

Europe PubMed Central

20 September 2017

John R Holt

4

1 reference

Europe PubMed Central

20 September 2017

G Eric Blair

6

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

338

1 reference

Europe PubMed Central

20 September 2017

297-308

1 reference

Europe PubMed Central

20 September 2017

2

1 reference

Europe PubMed Central

20 September 2017

Divergent and convergent evolution of NK-cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Expression and interactions of human adenovirus oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Adenovirus E1A: remodelling the host cell, a life or death experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Identification of genes associated with adenovirus 12 tumorigenesis by microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

The MHC class I antigen presentation pathway: strategies for viral immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Susceptibility to natural killer cells and down regulation of MHC class I expression in adenovirus 12 transformed cells are regulated by different E1A domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Tumorigenicity of adenovirus-transformed cells and their sensitivity to tumor necrosis factor α and NK/LAK cell cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

NK cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Surface receptors delivering opposite signals regulate the function of human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Natural killer function in flow cytometry. I. Evaluation of NK lytic activity on K562 cell line.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Lymphocyte-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

The level of expression of class-I MHC antigens in adenovirus-transformed human cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.05.017

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40408075&oldid=1897098366"